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Plasmacytoid Dendritic Cells Infiltrate the Skin in
Positive Tuberculin Skin Test Indurations
Emily Bond1,8, Frank Liang1,8, Kerrie J. Sandgren1, Anna Smed-So¨rensen2, Peter Bergman1,3,
Susanna Brighenti1, William C. Adams1, Senait A. Betemariam1, Molebogeng X. Rangaka4, Christoph Lange5,
Robert J. Wilkinson4,6,7, Jan Andersson1 and Karin Lore´1
Plasmacytoid dendritic cells (pDCs) are rarely present in normal skin but have been shown to infiltrate lesions
of infections or autoimmune disorders. Here, we report that several DC subsets including CD123þ BDCA-2/
CD303þ pDCs accumulate in the dermis in indurations induced by the tuberculin skin test (TST), used to screen
immune sensitization by Mycobacterium tuberculosis. Although the purified protein derivate (PPD) used in the
TST did not itself induce pDC recruitment or IFN-a production, the positive skin reactions showed high
expression of the IFN-a-inducible protein MxA. In contrast, the local immune response to PPD was associated
with substantial cell death and high expression of the cationic antimicrobial peptide LL37, which together can
provide a means for pDC activation and IFN-a production. In vitro, pDCs showed low uptake of PPD compared
with CD11cþ and BDCA-3/CD141þ myeloid DC subsets. Furthermore, supernatants from pDCs activated with
LL37–DNA complexes reduced the high PPD uptake in myeloid DCs, as well as decreased their capacity to
activate T-cell proliferation. Infiltrating pDCs in the TST reaction site may thus have a regulatory effect upon the
antigen processing and presentation functions of surrounding potent myeloid DC subsets to limit potentially
detrimental and excessive immune stimulation.
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INTRODUCTION
Tuberculin skin tests (TSTs) are performed by intradermal
injection of purified protein derivate (PPD), produced and
sterilized from multiple strains of Mycobacterium tubercu-
losis (Magnusson and Bentzon, 1958), and are clinically used
to evaluate immune sensitization by M. tuberculosis or
the Bacillus Calmette-Gue´rin vaccine. In sensitized indivi-
duals, a delayed-type hypersensitivity reaction is induced
at the injection site. The sequence of events leading to the
local immune reaction associated with a positive TST is
incompletely defined but is likely initiated by PPD uptake of
dendritic cells (DCs) in the skin for subsequent antigen
presentation and stimulation of M. tuberculosis-specific
memory T cells (Poulter et al., 1982; Scheynius et al.,
1982). DCs are known to orchestrate immune reactions
occurring at the interface of innate and adaptive immunity
(Banchereau et al., 2000). There are several distinct subsets
of DCs described, based on lineage origin and anatomical
location. DCs resident in the skin are almost exclusively
of the myeloid lineage. Recently, a distinctly different subset,
plasmacytoid DCs (pDCs), normally absent in skin,
were shown to migrate to inflamed skin lesions of auto-
immune reactions such as psoriasis (Nestle et al., 2005;
Albanesi et al., 2010) and lupus erythematosus (Farkas et al.,
2001; Meller et al., 2005), as well as to virally induced
lesions of herpes simplex (Donaghy et al., 2009; Peng et al.,
2009) and varicella (Gerlini et al., 2006; Huch et al., 2010).
pDCs are thought to have a central role in the response to
viruses through their capacity to produce high amounts of
IFN-a, which is primarily induced by microbial nucleic acid
signaling via Toll-like receptors 7 and 9 (Gilliet et al., 2008).
In addition, pDCs can produce IFN-a in response to human
(self) DNA or RNA if complexed to the antimicrobial peptide
LL37 (Lande et al., 2007; Ganguly et al., 2009). This complex
formation enables endocytosis of self-DNA and -RNA and
subsequent Toll-like receptor signaling in the endosome.
Thus, pDC may also regulate immune responses via IFN-a in
the absence of pathogen exposure.
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Figure 1. PPD-injected sites show increased cellularity and infiltration of dendritic cells (DCs). Cryosections of donor-matched skin punch biopsy
samples of the tuberculin skin test (TST) site were taken 48 hours post injection. Representative images are shown of saline-injected versus purified protein
derivate (PPD)-injected sites from TST-positive donors. Increased cellularity (a) as measured by cell nuclei counterstained blue with hematoxylin, and increased
expression (brown) of HLA-DR (b), Langerin (c), DC-SIGN (d), CD11c (e), CD68 (f), and CD141/BDCA-3 (g) at the TST site. All scale bars¼ 25mm. Note that
the dark basal membrane represents melanin-rich cells and not positive staining. (h) Bar graphs show mean±SEM. Data were collected from image analysis of
dermis only, except for Langerin, where epidermis only was analyzed. DC-SIGN, dendritic cell-specific intracellular adhesion molecule-3-grabbing
non-integrin.
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DC Subsets Infiltrate the TST Site
In this study, we investigated the presence and relative
roles of distinct DC subsets in the skin in the TST reaction. In
biopsy specimens from healthy individuals displaying a
positive TST, we found a large infiltration of several DC
subsets expressing markers associated with myeloid DCs
(mDCs) and pDCs. This was accompanied by upregulation of
the antimicrobial peptide LL37 and an increased expression
of multiple markers for cell death, suggesting the release of
self nucleic acids. No infiltration of cells was found after PPD
injection in individuals with a negative TST, nor did PPD
exposure activate DCs in vitro, suggesting that it is the milieu
in the positive TST reaction that leads to recruitment of DCs.
Supernatants from LL37–DNA-activated pDCs in vitro
reduced the otherwise high uptake of PPD by mDCs, induced
their maturation, as well as altered the activation of T-cell
proliferation and cytokine production profile. Infiltrating
pDCs may therefore show a regulatory function to control
the level of antigen presentation and immune activation in
the TST reaction.
RESULTS
DCs infiltrate the TST site
Cryosections of skin punch biopsy specimens taken at
48 hours after injection of PPD, or saline, in healthy donors
with a positive TST reaction were analyzed by immuno-
histochemistry and quantitative image analysis. Inflamma-
tion was observed in all positive TST sites as evidenced by a
significant increase in cellularity quantified by the area of
hematoxylin-stained nuclei in the tissue (Figure 1a and h,
P¼0.0008, n¼ 7). The efficiency of DCs to present PPD
antigen to CD4þ and CD8þ T cells, which are known to
infiltrate the positive TST reaction (Poulter et al., 1982;
Scheynius et al., 1982; Platt et al., 1983), likely depends on
both recruitment of DCs to the skin and their antigen-
processing capacity. To evaluate the degree of DC influx to
the TST site, we first assessed the level of MHC class II (HLA-
DR) expression. The percentage of HLA-DRþ area out of the
total area of the dermis was found to be significantly higher in
the TST reaction than in the donor-matched saline-injected
control sites (Figure 1b and h, P¼ 0.0019, n¼9). In the
controls, the majority of HLA-DRþ cells were typically
present in clusters in the dermis. In contrast, the HLA-DRþ
cells in the TST reaction were scattered throughout both the
dermis and epidermis, although predominantly in the
pericapillary areas. To further characterize these cells, a
series of well-defined markers were used. The C-type lectin
receptor Langerin, specific for Langerhans cells, was con-
stitutively present in the epidermis (Valladeau et al., 2003)
and significantly upregulated in the TST reaction (Figure 1c
and h, P¼0.0061, n¼8). Dendritic cell-specific intracellular
adhesion 3 grabbing was constitutively expressed in dermis
and significantly increased in the TST reaction (Figure 1d and
h, P¼0.0006, n¼ 8). Furthermore, CD11c (Figure 1e and h,
Pp0.0001, n¼ 8) and CD68 (Figure 1f and h, P¼0.0013,
n¼10), expressed by DCs of the myeloid lineage, as well as
macrophages, were almost exclusively present in the dermis
and markedly increased in the TST sites as compared with
controls. CD141 (BDCA-3), recently reported to define a
distinct myeloid DC subset (Jongbloed et al., 2010), was
absent or expressed at very low levels in the controls, but was
detected in all TST biopsy specimens (Figure 1g and h,
P¼0.0009, n¼10). In accordance with the fact that PPD is
designed to not induce immune activation in individuals
lacking preexisting immunity, there was no infiltration after
injection of individuals displaying a negative TST as
evidenced by the absence of increased cellularity or
expression of HLA-DR and CD11c (Figure 1h). From these
results, we concluded that multiple mDCs of the myeloid
lineage infiltrated the positive TST indurations.
pDCs are recruited to the positive TST site
As mentioned earlier, pDCs do not usually reside in the skin.
This was confirmed by rare or absent CD123 expression in
the saline controls. In contrast, CD123þ pDCs were present
in all positive TST biopsy samples (P¼0.0043, n¼10, Figure
2a and c). The expression of CD123 was confined to the
dermis and mainly found in clusters in which distinct
individual cells with high CD123 expression were discern-
ible. In addition, there was occasionally low-intensity CD123
staining in streak formations, presumably representing
endothelial cells as described (Hirbod et al., 2009). Another
pDC marker, CD303 (BDCA-2), was also significantly
upregulated in the TST sites (Pp0.0001, n¼9, Figure 2b
and d), and was highly co-expressed with CD123 (Figure 2f).
However, CD303 was less prevalent, consistent with its
documented downregulation on activated pDCs (Figdor
et al., 2002). No increase in CD123 or CD303 expression
was detected, indicating an absence of pDC recruitment,
in biopsy samples from individuals with a negative TST
(Figure 2e).
High expression of the IFN-a-inducible protein MxA and
cell-death markers in the TST reaction
Despite the infiltration of pDCs in response to the positive
TST, IFN-a was not detected (data not shown). In contrast,
staining of MxA, a GTPase specifically induced by IFN-a/-b
exposure (Simon et al., 1991; Fah et al., 1995), was readily
detected after PPD injection, whereas it was undetectable in
the saline controls (Figure 3a and d, Pp0.0001, n¼ 9). As the
presence of MxA strongly implies production of IFN-a/-b, the
time of biopsy sample collection, or production levels may
explain the lack of IFN-a detection. MxA was present not
only in the dermis, in close proximity to CD123þ CD303þ
pDCs, but also in the epidermis. It is plausible that pDC-
produced IFN-a/-b can diffuse through the tissue inducing
upregulation of MxA. Alternatively, cells in the epidermis
distinct from pDCs may have produced IFN-a. IFN-a
production by pDCs in psoriatic lesions, a non-pathogen-
containing, yet inflammatory, milieu, was recently demon-
strated to be induced by self-DNA or -RNA from dying cells
in complex with the antimicrobial peptide LL37 (Lande et al.,
2007; Ganguly et al., 2009). Analyses of the expression levels
of LL37 at the TST sites showed a strong upregulation in
dermis, compared with a low constitutive expression in the
controls (Figure 3b and d, Pp0.0001, n¼10). With regard to
cell death, the levels of active Caspase-3, primarily indicating
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apoptosis (Duan et al., 2003), were highly upregulated in the
positive TST site (Figure 3c and d, P¼0.0002, n¼9). PPD
injection per se induced no or a very small increase in MxA,
LL37, or Caspase-3 expression, as shown in donors with
negative TST reactions (Figure 3d). High intracellular and
extracellular presence of high-mobility group protein B-1
(Figure 3e) and lactate dehydrogenase (Figure 3f) in the TST
sites indicated leakage of these proteins due to loss of cell
membrane integrity associated with necrosis in particular
(Scaffidi et al., 2002; Duan et al., 2003; Yun et al., 2008;
Morishima et al., 2010). This cell leakage implies a
simultaneous release of self nucleic acids from cells under-
going necrosis or secondary apoptosis in the TST reaction,
which could thus be available for complex formation with the
high levels of LL37.
Differential capacity for PPD uptake in DC subsets
To investigate DC functions pertaining to uptake and
processing of PPD for antigen presentation, and whether a
milieu of LL37–DNA complexes influenced this, we con-
ducted experiments in vitro using isolated DC subsets. pDCs
are generally considered to be inefficient at antigen
presentation compared with other DC subsets, which may
partially relate to lesser capacity to internalize antigens
(Villadangos and Young, 2008). To this end, CD123þ pDCs
and CD11cþ mDCs were pulsed with fluorescently labeled
PPD for 2 hours. The internalization of PPD was assessed
by comparing PPD binding at 4 1C with active uptake at
37 1C by flow cytometry, as well as by verifying intracellular
punctuate signals by microscopy (Figure 4a). pDCs showed
significantly lower uptake of PPD compared with both
conventional mDCs (P¼ 0.0008) and cross-presenting
CD141þ DCs (Figure 4b and c, P¼0.02, n¼3).
LL37–DNA-stimulated pDCs can regulate mDCs and T-cell
function
In line with earlier reports (Lande et al., 2007; Ganguly et al.,
2009), we found that IFN-a secretion by pDCs exposed to
complexes of LL37 and human DNA was enhanced compared
with the low levels found in response to either LL37 or DNA
alone (Figure 4d). This was even more pronounced using
complexes of LL37 and synthetic CpG ODN. LL37–DNA
complexes also induced phenotypic maturation in pDCs as
evidenced by upregulation of CD40, CD80, and CD86 (Figure
4e). Exposure of pDCs to PPD alone did not induce IFN-a or
maturation. mDCs did not show any detectable IFN-a or
maturation in response to either PPD or LL37–DNA (data
not shown). In contrast, mDCs matured when exposed to
supernatants from LL37–DNA-exposed pDCs (Figure 4f).
Further, the high uptake of PPD by mDCs was significantly
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Figure 2. Recruitment of CD123þCD303þ pDCs to the TST site.
Plasmacytoid dendritic cells (pDCs) were detected by expression of both
CD123 (a, c) and CD303 (BDCA-2) (b, d), and were significantly increased at
the purified protein derivate (PPD) injection site of tuberculin skin test (TST)-
positive individuals. The expression was restricted to the dermis. Bars¼ 25mm.
Note that the dark basal membrane represents melanin-rich cells and not
positive staining. All graphs show mean±SEM. (e) pDCs were not recruited to
the site of PPD injection in TST-negative individuals. (f) Representative
immunofluorescent costaining (which appears yellow) of CD123 (green) and
CD303 (red) to confirm the presence of pDCs at the TST site.
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reduced when cultured in the presence of pDC supernatants
(Figure 4g). This reduced capacity to internalize PPD
was unlikely to be due to IFN-a alone, as the addition of
recombinant IFN-a at similar levels as in the pDC supernatants
did not reproduce this effect. Importantly, LL37–DNA com-
plexes alone did not reduce PPD uptake in mDCs (data not
shown). The decreased PPD uptake by mDCs caused by pDC
supernatants is unlikely to exclusively relate to the functional
transformation associated with maturation, as the effect was
observed as early as after 2 hours of incubation with super-
natants (data not shown). Finally, mDCs exposed to pDC
supernatants showed significantly reduced capacity to stimu-
late allogeneic CD4þ T-cell proliferation as evidenced by both
carboxyfluorescein succinimidyl ester dilution (Figure 5a,
representative of seven donors) and thymidine incorporation
assays (Figure 5b, n¼4, P¼0.02). Again, IFN-a alone did not
have the same effect. LL37–DNA-exposed pDCs also directly
suppressed T-cell proliferation found in pDC/T-cell cocultures
(Figure 5c, P¼ 0.035, n¼ 4). In addition to reduced prolifera-
tion, T cells cocultured with mDCs exposed to pDC super-
natant showed altered production of effector cytokines IL-2,
tumor necrosis factor-a, and IFN-g as measured by intracel-
lular cytokine staining (Figure 5d, P¼ 0.0036, n¼ 8). Further,
separate assessment showed that the production of IL-2
was particularly reduced, whereas the levels of tumor necrosis
factor-a and IFN-g remained unchanged (Figure 5e). This
concurred with elevated production of IL-6 and IL-10. Thus,
pDCs activated by LL37–DNA complexes in the TST site
may acquire a function to regulate immune activation
by directly or indirectly skewing cytokine production and
controlling proliferation of T cells.
DISCUSSION
pDCs have emerged as a highly specialized DC subset that
has been shown to possess poorer antigen uptake and
presentation capacity compared with other DC subsets, but
instead equipped with a high capacity to produce IFN-a/-b
(Cella et al., 1999). Thus, their role in controlling viral
infections has been particularly explored. However, pDCs
have also shown to exert other immunoregulatory properties
not involving pathogen responses (Swiecki and Colonna,
2010). Indeed, pDCs were initially described for their role in
maintaining tolerance. High levels of pDCs were shown to
represent a good prognostic factor for discontinuation of
immunosuppressive treatment after liver and stem cell
transplantation, and may hence be important to prevent
transplant rejection or graft-versus-host disease, respectively,
(Mazariegos et al., 2003; Rajasekar et al., 2008). To this end,
pDCs were shown to mediate oral tolerance to food antigens
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(a, d) High expression of the IFN-a-inducible protein MxA in the tuberculin
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associated with cell death, was also increased (c, d). These increases were not
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group protein B-1 (HMGB-1) (red) and (f) lactate dehydrogenase (LD) (red)
together with HLA-ABC (green) and 40,6-diamidino-2-phenylindole (blue).
(e, f) Arrows denote extracellularly located HMGB-1 and LD as a possible
consequence of leakage out of necrotic cells. Bars¼25 mm. All graphs show
mean±SEM.
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by suppressing CD4þ and CD8þ T-cell-specific delayed-
type hypersensitivity responses (Goubier et al., 2008). The
TST reaction examined in this study also represents delayed-
type hypersensitivity. A role for DCs in the development of
positive TST reactions was early implied (Scheynius et al.,
1982; Beck, 1991; Sarrazin et al., 2009). Our data indicate
that there is a rapid and rather robust infiltration of several
DC subsets, including pDCs in the positive TST reaction. As
this was not found in negative TST, the inflammation induced
locally by infiltrating, presumably PPD-specific, T cells likely
regulates the pDC recruitment. Although pDCs are not
normally located in the skin, they are recruited to allergic
contact hypersensitivity reactions (Bangert et al., 2003), as well
as to the autoimmune reactions associated with lupus
erythematosus (Farkas et al., 2001; Meller et al., 2005) and
psoriasis (Nestle et al., 2005; Albanesi et al., 2010). In the latter,
infiltrated pDCs were shown to produce IFN-a. The classical
stimuli that induce high levels of IFN-a in pDCs are nucleic
acids derived from microbes activating cells via intracellular
Toll-like receptor signaling (Stacey et al., 2003; Akira et al.,
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2006). However, recent reports show that pDCs can react to
human RNA or DNA if they are presented as complexes with
(the antimicrobial peptide) LL37 (Lande et al., 2007; Ganguly
et al., 2009). These studies prompted our further investigation of
whether LL37 was upregulated at the TST sites and whether this
occurred simultaneously with cell death, leading to the release
of nucleic acid material. On the basis of our data showing high
levels of LL37 and signs of necrotic tissue, we speculate that
LL37–DNA complexes may also be available and activate pDCs
that infiltrate the TST sites. In this regard, pDCs could also be
activated by complexes formed by self-DNA and the high
levels of high-mobility group protein B-1 at the TST site
(Tian et al., 2007). Because of the quite distinct differences in
the characteristics of DC subsets, they likely possess different
and complementary functions to generate, enhance, or suppress
immune responses. pDCs showed significantly lower capacity
to take up PPD than the mDC subsets. This included the distinct
CD141þ mDC subset with superior cross-presenting capacity
(Bachem et al., 2010; Jongbloed et al., 2010; Villadangos and
Shortman, 2010). Infiltration of CD141þ DCs in response to
antigen delivery and inflammation in the skin has not been
described previously and it is possible they activate PPD-
specific CD8þ T cells in the TST reaction. As pDCs showed
much lower uptake of PPD, their primary contribution in the
TST reaction may not pertain to antigen processing and
presentation to T cells. Instead, they may have an important
bystander effect of conditioning surrounding mDC subsets.
This bystander effect could consist of a suppressor function to
restrain otherwise potentially harmful, excessive immune activa-
tion. Although pDCs have been identified to mediate immune
responses in skin inflammation in psoriasis (Lande et al., 2007)
and wound healing (Gregorio et al., 2010), they may also
function to regulate the magnitude of the responses. On this
note, pDCs have shown different immune-stimulatory capacities
at different differentiation/activation stages (Hadeiba et al.,
2008; Schwab et al., 2010; Bjorck et al., 2011). The nature of
the antigen likely also has a role in shaping pDC function.
We found that supernatants from pDCs stimulated by
LL37–DNA complexes reduced the high capacity of mDCs
to take up PPD. This reduction may in part be mediated by
IFN-a, although it was evident in our experiments that this it
was not the sole factor. Anti-IFN-a/-b antibodies have been
shown to block maturation of mDCs (Ganguly et al., 2009),
and thus IFN-b could potentially also mediate this effect.
Here, mDCs cultured in the presence of pDC supernatants
showed reduced capacity to induce effector cytokine
production and proliferation of allogeneic CD4þ T cells.
Type-I IFN produced by pDCs has been shown to limit T-cell
proliferation (Chi et al., 2006), but again the inhibition we
observed was not evident with exposure to recombinant IFN-
a alone, suggesting that there are alternative suppressive
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exposed overnight to indicated stimuli. (c) T-cell proliferation after 5 days of
coculture of T cells and plasmacytoid dendritic cells (pDCs) exposed to
indicated stimuli. (d) Frequencies of cytokine (IL-2, tumor necrosis factor-
(TNF)a, IFN-g) producing CD4þ T cells measured by intracellular staining
after coculture for 16 hours with mDCs exposed overnight to the indicated
stimuli and (e) levels of IL-2, IL-6, IL-10, TNF-a, and IFN-g in supernatants
from mDC–T-cell cocultures pulsed with staphylococcal enterotoxin B (SEB).
c.p.m., counts per minute.
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mediators released from the pDCs. Taken together, our data
suggest that mDC subsets would take up more PPD delivered
at the site of injection than pDCs, and consequently are most
likely to perform the majority of the antigen presentation
to activate antigen-specific memory T cells. pDCs could still
contribute to these functions; however, as mDCs are by far
the most frequent DC subsets at the site, even after PPD
injection, the uptake and presentation by pDCs may be
negligible. Instead, pDCs activated by components from the
local inflammation and tissue destruction may partake
in controlling the magnitude of immune responses by
directly exerting a regulatory effect on T-cell activation or
by influencing the functions of mDCs. In our in vitro studies,
we found that LL37–DNA-activated pDCs can suppress
T-cell proliferation and skew the cytokine production. To
this end, pDCs have, under other culture conditions, shown
to restrain T-cell activation by inducing T-regulatory cells
(Moseman et al., 2004; Varani et al., 2007). However,
these interactions remain to be shown in the skin in vivo.
In addition, the kinetics by which the different DC subsets
and T cells are recruited after PPD injection could influence
the regulation of T-cell activation but are still to be
determined. In conclusion, our data further elucidate the
emerging multifacetted roles that pDCs have in shaping
immune responses. Understanding the different roles of the
specific DC subsets infiltrating the skin is critical for defining
the responses elicited to pathogens targeting the skin, as well
as for the development of new therapies, vaccines, and
delivery strategies.
MATERIALS AND METHODS
Collection of human skin punch biopsy specimens
Written informed consent was obtained from all study subjects. The
Karolinska Institutet and University of Cape Town Institutional
Review Boards approved the experiments, and they were conducted
in adherence with the Declaration of Helsinki Principles. Study
subjects were recruited in Khayelitsha Township, Cape Town, South
Africa. Exclusion criteria are described earlier (Rangaka et al., 2007)
and included previously diagnosed tuberculosis, HIV infection, and/
or presentation of one of several symptoms, e.g. cough, chest pain,
or fever. TST was performed according to international standards and
considered positive at X10 mm. The study subjects who displayed a
positive TST reaction showed mean 18.6±2.3 mm. Punch biopsy
samples were taken as described (Sarrazin et al., 2009) from the PPD
injection site and a saline-injected site on the opposite arm at
48 hours and snap-frozen.
Immunohistochemical staining and quantitative image analysis
Cryosections (8mm) of skin biopsy samples were stained as described
(Lore et al., 2002) with anti-HLA-DR, CD11c, CD123, CD8, active
Caspase-3 (BD Biosciences, San Jose´, CA), CD68 (Dako, Glostrup,
Denmark), CD303 (BDCA-2), dendritic cell-specific intracellular
adhesion 3 grabbing, Langerin (R&D Systems, Minneapolis, MN),
LL37 (Innovagen, Lund, Sweden), CD141 (BDCA-3) (Miltenyi
Biotech, Auburn, CA), MxA (Professor Haller and Kochs, University
of Freiburg, Germany), followed by secondary biotinylated
antibodies (Abs), i.e., anti-mouse, anti-goat (Dako), or anti-rabbit
(Vector Laboratories, Burlingame, CA). The secondary Abs were
detected with the peroxidase-based Vectastain Elite ABC kit (Vector
Laboratories), and the reaction developed by diaminobenzidine
tetrahydrochloride peroxidase substrate kit (Vector Laboratories).
Cell nuclei were counterstained with Mayer’s Haematoxylin
(Histolab Products, Gothenburg, Sweden). The sections were
analyzed by a Leica DMR-X microscope (Leica Microsystems
GmbH, Wetzlar, Germany) coupled to computerized image analysis
(Leica Qwin 5501W, Leica Imaging Systems) as described (Bjork
et al., 1996). The epidermis was excluded from the analysis of all
markers except for Langerin, where the dermis was excluded.
Analyses were confirmed by at least two separate investigators.
Fluorescent costaining
The stainings were performed as above with modifications. Follow-
ing the incubation with the secondary biotinylated Abs, streptavidin-
conjugated Alexa488 or Alexa647 (Molecular Probes, Eugene, OR)
was added or, alternatively, Alexa594-conjugated secondary Abs
were used. In addition to the cell-specific Abs mentioned above,
anti-HLA-ABC (Dako), lactate dehydrogenase (Abcam, Cambridge,
UK), high-mobility group protein B-1 (BD Biosciences), and
Alexa594-labeled anti-goat (Molecular Probes) antibodies were
used. Sections were mounted using SlowFade Gold antifade regent
with 40,6-diamidino-2-phenylindole (Invitrogen, Carlsbad, CA) for
nuclear staining.
Isolation of blood pDCs and mDCs
Primary DCs were purified from blood as described (Adams et al.,
2009; Douagi et al., 2009; Adams et al., 2011). In short, pDCs and
mDCs were isolated from buffy coats treated with monocyte-
enrichment cocktail (RosetteSep, Stemcell Technologies, Grenoble,
France) or elutriated monocytes by anti-BDCA-4 and anti-CD1c
microbeads (Miltenyi Biotech) and AutoMACS separation (Miltenyi
Biotech). pDCs and mDCs were cultured in RPMI-1640 with 10%
fetal calf serum (Sigma-Aldrich, Schelldorf, Germany) supplemented
with IL-3 (1 ng ml1; R&D Systems) and GM-CSF (2 ng ml1;
PeproTech, Rocky Hill, NJ), respectively.
Stimulation of pDCs with LL37–DNA complexes
Complexes were formed by co-incubation of either 10mg ml1
human DNA (Biochain Institute, Hayward, CA) or 5mg ml1 CpG
ODN (class B 10103, Coley Pharmaceutical Group GmbH,
Du¨sseldorf, Germany) with 10–50mg ml1 LL37 (Innovagen, Lund,
Sweden) for 30 minutes at room temperature. pDCs were exposed to
the complexes at 1 106 per ml for 16 hours at 37 1C. Cell-free
supernatants were collected and analyzed. Supernatants of pDCs
stimulated by CpG–LL37 complexes were used for culture experi-
ments with mDCs.
Analysis of cytokine production and maturation of DCs
IFN-a was measured in supernatants from pDCs by ELISA (VeriKine,
PBL Interferon Source, Piscataway, NJ). For analysis of phenotypic
maturation, isolated DCs were stained with combinations of Abs,
including CD1c, CD11c, CD123, CD80, CD83, and CD86 as
described (Lore et al., 2005). The cells were collected on a
FACSCalibur flow cytometer (BD Biosciences) and data were
analyzed using FlowJo software (Treestar, San Carlos, CA). Luminex
assays (Human Cytokine 10-Plex Panel, Invitrogen), for analysis
of cytokines in supernatants from DC and DC/T-cell cultures,
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were performed according to the manufacturer’s instructions and
analyzed by Luminex 200 system (Invitrogen).
Evaluation of PPD uptake capacity
PPD (Statens Serum Institut, Copenhagen, Denmark) was labeled by
using an Alexa488 protein labeling kit (Molecular Probes). Isolated
pDCs and mDCs were pulsed with 4mg ml1 PPD-Alexa488 for
2 hours at 37 or 4 1C and analyzed by flow cytometry. Alternatively,
2 106 cells of monocyte-enriched populations (RosetteSep, Stem-
cell Technologies) were exposed to PPD-Alexa488 for 2 hours and
cells expressing CD11c, CD123, or CD141 were analyzed.
For confocal microscopy imaging, sorted pDCs and mDCs were
transferred to adhesion slides (BioRad Lab, Munich, Germany) as
described (Bond et al., 2009). The slides were mounted with
Vectashield mounting medium containing 40,6-diamidino-2-pheny-
lindole (Vector Laboratories) for nuclear staining.
Functional assays of pDC effects on mDCs
IFN-a at 1,000–5,000 U ml1 or supernatants from pDCs at 1:1 were
added to cultures of mDCs. mDCs were incubated for 24 hours,
washed, exposed to PPD-Alexa488 for 2 hours, and analyzed for
PPD uptake and CD80/CD86 expression. For analysis of T-cell
stimulatory capacity, pDCs or mDCs were cocultured with
unlabeled or carboxyfluorescein succinimidyl ester-labeled, purified
allogeneic CD4þ T cells obtained (as described by Adams et al.,
2011) at a ratio of 1:10 for 16 hours for detection of IL-2, tumor
necrosis factor-a, and IFN-g expression by intracellular staining and
FACS analysis, or for 5 days for assessment of proliferation, as
described (Lore et al., 2005; Adams et al., 2011). Alternatively,
proliferation was measured by thymidine incorporation as described
(Gujer et al., 2011).
Statistical analyses
Data were analyzed by Student’s t-test, with GraphPad Prism
software (San Diego, CA), and considered significant at *Pp0.05,
**Pp0.01, and ***Pp0.001.
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